Identification of transmembrane protein in prostate cancer by the escherichia coli ampicillin secretion trap: Expression of CDON is involved in tumor cell growth and invasion

Pathobiology

Volumn 78, Issue 5, 2011, Pages 277-284

  Hayashi, Tetsutaro ^a   Oue, Naohide ^a   Sakamoto, Naoya ^a   Anami, Katsuhiro ^a   Oo, Htoo Zarni ^a   Sentani, Kazuhiro ^a   Ohara, Shinya ^a   Teishima, Jun ^a   Matsubara, Akio ^a   Yasui, Wataru ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

CDON; Escherichia coli ampicillin secretion trap; Prostate cancer

Indexed keywords

CELL SURFACE RECEPTOR; FLUOROURACIL; MEMBRANE PROTEIN; PEPTIDE LIBRARY; PROTEIN CDO; UNCLASSIFIED DRUG;

ADAM9 GENE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CDON GENE; CONTROLLED STUDY; ESCHERICHIA COLI AMPICILLIN SECRETION TRAP; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; HUMAN TISSUE; MOLECULAR LIBRARY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; STEAP1 GENE; TUMOR GENE;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CELL ADHESION MOLECULES; ESCHERICHIA COLI; GENE EXPRESSION PROFILING; GENE LIBRARY; GENETIC TECHNIQUES; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

ESCHERICHIA COLI;

EID: 80051626841     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000329588     Document Type: Article

References (26)

1. Baade PD, Youlden DR, Krnjacki LJ: International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009; 53: 171-184.
2. Carter HB: Prostate cancers in men with low PSA levels-must we find them? N Engl J Med 2004; 350: 2292-2294.
3. Chang SS, Kibel AS: The role of systemic cytotoxic therapy for prostate cancer. BJU Int 2009; 103: 8-17.
4. Isaacs W, De Marzo A, Nelson WG: Focus on prostate cancer. Cancer Cell 2002; 2: 113-116. (Pubitemid 41039111)
5. Buckhaults P, Rago C, St Croix B, et al: Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001; 61: 6996-7001. (Pubitemid 32946484)
6. Ferguson DA, Muenster MR, Zang Q, et al: Selective identification of secreted and transmembrane breast cancer markers using Escherichia coli ampicillin secretion trap. Cancer Res 2005; 65: 8209-8217. (Pubitemid 41330584)
7. von Heijne G: A new method for predicting signal sequence cleavage sites. Nucleic Acids Res 1986; 14: 4683-4690.
8. Kadonaga JT, Gautier AE, Straus DR, Charles AD, Edge MD, Knowles JR: The role of the-lactamase signal sequence in the secretion of proteins by Escherichia coli . J Biol Chem 1984; 259: 2149-2154. (Pubitemid 14190323)
9. Anami K, Oue N, Noguchi T et al: Search for transmembrane protein in gastric cancer by the Escherichia coli ampicillin secretion trap: expression of DSC2 in gastric cancer with intestinal phenotype. J Pathol 2010; 221: 275-284.
10. Kang JS, Gao M, Feinleib JL, Cotter PD, Guadagno SN, Krauss RS: CDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat family. J Cell Biol 1997; 138: 203-213. (Pubitemid 27337464)
11. Kang JS, Mulieri PJ, Hu Y, Taliana L, Krauss RS: BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation. EMBO J 2002; 21: 114-124. (Pubitemid 34087080)
12. Gibson UE, Heid CA, Williams PM: A novel method for real time quantitative RT-PCR. Genome Res 1996; 6: 995-1001. (Pubitemid 26388092)
13. Kondo T, Oue N, Yoshida K, et al: Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004; 64: 523-529. (Pubitemid 38120891)
14. Yasui W, Sano T, Nishimura K, et al: Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer 1993; 54: 49-52. (Pubitemid 23136998)
15. Alley MC, Scudiero DA, Monks A, et al: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601. (Pubitemid 18056527)
16. Sakamoto N, Oue N, Noguchi T, et al: Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma. Cancer Sci 2010; 101: 1038-1044.
17. Challita-Eid PM, Morrison K, Etessami S, et al: Monoclonal antibodies to six-transmembrane epithelial antigen of the prostate-1 inhibit intercellular communication in vitro and growth of human tumor xenografts in vivo. Cancer Res 2007; 67: 5798-5805. (Pubitemid 46985013)
18. Fritzsche FR, Jung M, Tlle A, et al: ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur Urol 2008; 54: 1097-1106.
19. Izumi Y, Hirata M, Hasuwa H, et al: A metalloprotease-disintegrin, MDC9/meltrin-/ ADAM9 and PKC- are involved in TPA-induced ectodomain shedding of membraneanchored heparin-binding EGF-like growth factor. EMBO J 1998; 17: 7260-7272.
20. Peduto L, Reuter VE, Shaffer DR, Scher HI, Blobel CP: Critical function for ADAM9 in mouse prostate cancer. Cancer Res 2005; 65: 9312-9319. (Pubitemid 41507998)
21. Josson S, Anderson CS, Sung SY, et al: Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate 2011; 71: 232-240.
22. McLellan JS, Zheng X, Hauk G, Ghirlando R, Beachy PA, Leahy DJ: The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla. Nature 2008; 455: 979-983.
23. Zhang W, Kang JS, Cole F, Yi MJ, Krauss RS: CDO functions at multiple points in the Sonic Hedgehog pathway, and CDO-deficient mice accurately model human holoprosencephaly. Dev Cell 2006; 10: 657-665.
24. Pasca di Magliano M, Hebrok M: Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003; 3: 903-911. (Pubitemid 37500175)
25. Bale AE: Hedgehog signaling and human disease. Annu Rev Genomics Hum Genet 2002; 3: 47-65. (Pubitemid 35217430)
26. Sanchez P, Hernández AM, Stecca B, et al: Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOGGLI1 signaling. Proc Natl Acad Sci USA 2004; 101: 12561-12566. (Pubitemid 39122063)